Início › Melanoma › Pensilvânia

Ensaios clínicos de Melanoma em Pensilvânia

47 estudos para Melanoma estão buscando participantes em locais em Pensilvânia.

Cidades em Pensilvânia

Texto oficial do estudo (Inglês)

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Lehigh Valley Hospital-Cedar Crest, Allentown
Lehigh Valley Hospital - Muhlenberg, Bethlehem
Geisinger Medical Center, Danville
e mais 7

RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos

Idades de 40 a 75 · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05334069

DESTINY-PANTUMOUR04

Research Site, Philadelphia

RecrutandoEstudo observacional

Idades de 18 a 130 · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07124000

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Thomas Jefferson University Hospital, Philadelphia

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT05136196

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

St. Luke's University Health Network, Easton
Penn State Health Milton South Hershey Medical Center, Hershey
Fox Chase Cancer Center, Philadelphia
e mais 1

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06246916

Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

Allegheny Health Network, Pittsburgh

RecrutandoFase 3

Idades de 18 a 70 · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT05727904

A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information

Children's Hospital of Philadelphia, Philadelphia
Children's Hospital of Pittsburgh of UPMC, Pittsburgh

RecrutandoFase 2

Até 25 anos · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT07621614

Pan-tumor MRD Study

Lancaster General Hospital (UPenn), Lancaster
Guthrie Foundation, Sayre
Cancer Care Associates of York (CCAY), York

RecrutandoEstudo observacional

Idades 18 e acima · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT06605404

Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

Christiana Care Health System-Concord Health Center, Chadds Ford
Fox Chase Cancer Center - East Norriton Hospital Outpatient Center, East Norriton
UPMC Hillman Cancer Center Erie, Erie
e mais 4

RecrutandoFase 3

Idades 75 e acima · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT07068074

BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)

University of Pennsylvania, Philadelphia

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 18 de set. de 2026 · NCT04752826

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

University of Pittsburgh Cancer Institute (UPCI), Pittsburgh

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 15 de set. de 2026 · NCT04511013

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

University of Pennsylvania, Philadelphia
WellSpan Medical Oncology & Hematology at York Cancer Center, York

RecrutandoEstudo observacional

Idades 18 e acima · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT05059444

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

University of Pittsburgh Medical Center, Pittsburgh

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 2 de set. de 2026 · NCT07070232

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

UPMC Hillman Cancer Center, Pittsburgh

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 31 de ago. de 2026 · NCT05896839

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Children's Hospital of Philadelphia, Philadelphia
Children's Hospital of Pittsburgh of UPMC, Pittsburgh

RecrutandoFase 1/2

12 Months – 30 Years · Todos os sexos · Atualizado em 25 de ago. de 2026 · NCT04851119

Project: Every Child for Younger Patients With Cancer

Lehigh Valley Hospital-Cedar Crest, Allentown
Geisinger Medical Center, Danville
Penn State Children's Hospital, Hershey
e mais 4

RecrutandoEstudo observacional

Até 25 anos · Todos os sexos · Atualizado em 25 de ago. de 2026 · NCT02402244

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

Research Site, Pittsburgh

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 19 de ago. de 2026 · NCT07115043

Investigating Real-Time Immunotherapy Symptoms Study

UPMC Hillman Cancer Center, Pittsburgh

Recrutando

Idades 18 e acima · Todos os sexos · Atualizado em 4 de ago. de 2026 · NCT07280715

Tebentafusp-tebn With LDT in Metastatic UM

Thomas Jefferson University, Philadelphia

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 21 de jul. de 2026 · NCT06626516

Safety and Efficacy of OBX-115 in Advanced Solid Tumors

Allegheny Research Institute (Melanoma/NSCLC), Pittsburgh

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 16 de jul. de 2026 · NCT06060613

Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies

UPMC Hillman Cancer Center, Pittsburgh

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 23 de jun. de 2026 · NCT04114136

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

UPMC Hillman Cancer Center, Pittsburgh

RecrutandoFase 1/2

Idades de 18 a 70 · Todos os sexos · Atualizado em 11 de jun. de 2026 · NCT05361174

Evolution of Metabolic and Immune Dysfunction in In-transit Melanoma

UPMC Hillman Cancer Center, Pittsburgh

RecrutandoEstudo observacional

Idades 18 e acima · Todos os sexos · Atualizado em 11 de jun. de 2026 · NCT04658303

Evaluation of Hypoxia in Primary Melanoma

UPMC Hillman Cancer Center, Pittsburgh

RecrutandoEstudo observacional

Idades 18 e acima · Todos os sexos · Atualizado em 10 de jun. de 2026 · NCT06831071

MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma

Fox Chase Cancer Center, Philadelphia
UPMC Hillman Cancer Center, Pittsburgh

RecrutandoFase 1/2

Idades de 18 a 90 · Todos os sexos · Atualizado em 10 de jun. de 2026 · NCT05655312

Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 8 de jun. de 2026 · NCT03947385

Study of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in Melanoma

Fox Chase Cancer Center, Philadelphia

RecrutandoFase 1 inicial

Idades 18 e acima · Todos os sexos · Atualizado em 22 de mai. de 2026 · NCT05498792

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

University of Pennsylvania, Perelamn Center for Advanced Medicine, Philadelphia
Thomas Jefferson University, Honickman Center, Philadelphia
Fox Chase Cancer Center, Philadelphia
e mais 1

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 13 de mai. de 2026 · NCT03686124

Neoadjuvant Darovasertib in Primary Uveal Melanoma

Jefferson Health Honickman Center, Philadelphia
UPMC Hillman Cancer Center, Pittsburgh

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 6 de mai. de 2026 · NCT07015190

A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

University of Pittsburgh Medical Center - Hillman Cancer Center, Pittsburgh

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 28 de abr. de 2026 · NCT06413680

A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma

UPenn, Philadelphia

RecrutandoFase 2/3

Idades 18 e acima · Todos os sexos · Atualizado em 22 de abr. de 2026 · NCT06624644

A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors

UPMC Hillman Cancer Center, Pittsburgh

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 20 de abr. de 2026 · NCT06326411

Patient Preference for Subcutaneous vs. Intravenous Immune Therapy

UPMC Hillman Cancer Center, Pittsburgh

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 16 de abr. de 2026 · NCT07223424

RP1 in Primary Melanoma to Reduce the Risk of Sentinel Lymph Node Metastasis

UPMC Hillman Cancer Center, Pittsburgh

RecrutandoFase 1 inicial

Idades 18 e acima · Todos os sexos · Atualizado em 13 de abr. de 2026 · NCT06216938

A Study of VET3-TGI in Patients With Solid Tumors

UPMC- Hillman Cancer Center, Pittsburgh

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 7 de abr. de 2026 · NCT06444815

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

Thomas Jefferson University, Philadelphia
UPMC Hillman Cancer Center, Pittsburgh

RecrutandoFase 2/3

Todas as idades · Todos os sexos · Atualizado em 2 de abr. de 2026 · NCT06581406

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Lehigh Valley Hospital-Cedar Crest, Allentown
Lehigh Valley Hospital - Muhlenberg, Bethlehem
WellSpan Medical Oncology and Hematology, Chambersburg
e mais 13

RecrutandoEstudo observacional

Idades 18 e acima · Todos os sexos · Atualizado em 17 de mar. de 2026 · NCT06418204

Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)

Thomas Jefferson University Medical Oncology Clinic, Philadelphia
UPMC Hillman Cancer Center, Pittsburgh

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 25 de fev. de 2026 · NCT05549297

Nilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Melanoma

St. Luke's University Health Network, Easton

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 13 de fev. de 2026 · NCT04903119

Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic Nevi

UPMC Hillman Cancer Center, Pittsburgh

RecrutandoEstudo observacional

Idades 18 e acima · Todos os sexos · Atualizado em 26 de jan. de 2026 · NCT06599619

Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients

Penn State Cancer Institute, Hershey
Fox Chase Cancer Center 333 Cottman Avenue, Philadelphia

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 17 de dez. de 2025 · NCT03567889

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.